With this type of sales interest, Freedom Leaf is projecting
revenue of $2,000,000 for the Hempology product line for 2018
Las Vegas, NV -- February 28, 2018 -- InvestorsHub NewsWire --
Freedom Leaf, Inc.
(OTCQB: FRLF), a group of
diversified, international, vertically-integrated Cannabis/Hemp
business and media companies, today announced that it is developing
multiple strategic partnerships through their wholly owned
extraction division Leafceuticals Inc., and through their
exclusively owned CBD product line Hempology.
Freedom Leaf has signed a National Distribution Agreement with
Quality Products Distribution Inc., the distributor of
the Accuvape vaporizer line. Hilary
Dulany, CEO of Quality Products Distribution Inc., signed the
agreement alongside Clifford Perry, CEO of Freedom Leaf, for
distribution rights of the Hempology CBD
line to their large network of retail stores across
the country. With this type of sales interest, Freedom Leaf is
projecting revenue of $2,000,000 for the Hempology product line for
2018.
Chris Thompson, Freedom Leaf’s Director of Digital Marketing,
who helped close the Distribution Agreement, explained, “Signing a
national distributor like Quality Products Distribution Inc. was
one of our major goals with the Hempology line. Now that Hilary’s
experienced sales team will be presenting our CBD products to
dispensaries and retail stores, we expect a steady growth of
wholesale orders in the coming weeks.”
In addition to the new Distribution Agreement, the Hempology CBD
product line will also now be available in brick and mortar retail
stores in over 10 states due to a large influx of wholesale orders
from the recent Champs Trade Show and Tobacco Plus Expo in Las
Vegas.
Freedom Leaf CEO and Co-Founder, Clifford Perry, stated, “We are
creating a strong foundation for our international company through
multiple positive relationships with key industry players. These
strategic partnerships will continue to bring Freedom Leaf to the
forefront of the emerging Cannabis/Hemp industry.”
Freedom Leaf’s extraction division, Leafceuticals
Inc., has completed a successful extraction of nearly 600
pounds of industrial hemp from Pahrump, NV and will be utilizing
the high-quality full-spectrum CBD oil directly in the Hempology
CBD product line.
Through the strategic
partnership with
manufacturer NutraFuels (OTCMKTS:
NTFU), Freedom Leaf will be able to capitalize on the full
retail value of the first industrial hemp CBD extraction by
manufacturing the Hempology line with their own extracted CBD. This
move will cut production costs of the Hempology CBD line and moves
Freedom Leaf towards being a fully vertically-integrated
company.
About Freedom Leaf®
Freedom Leaf, Inc., The Marijuana Legalization Company®, is a
fully-reporting and audited, publicly-traded company trading under
the symbol (OTCQB: FRLF), a group of
diversified, international, vertically-integrated Cannabis/Hemp/CBD
businesses and media companies
Freedom Leaf, Inc. is a leading, go-to resource in the cannabis,
medical and recreational marijuana, CBD and industrial hemp
industries. It is involved in mergers and acquisitions in
these industries, including acceleration and spin offs of new
companies involved in those industries.
Freedom Leaf Inc.'s flagship publication
is Freedom Leaf Magazine, The Good
News in Marijuana Reform. The company produces a portfolio of news,
print and digital multi-media verticals, websites, and web
advertising, for the ever changing emerging cannabis, medical
marijuana and industrial hemp industry. The Company also
controls LaMarihuana.com, the world’s leading
Spanish publication focused on these industries.
Freedom Leaf, Inc. does not handle, grow, sell, or
dispense marijuana or related products.
All of our European activities are in full compliance
with relevant EU laws.
Investor relations information can be found on
the FreedomLeafInc.com company
website.
Safe Harbor Statement
Statements in this press release that are not strictly
historical are "forward-looking" statements within the meaning of
Section 27A of the Securities Act of 1933, as amended and Section
21E of the Securities Exchange Act of 1934, as amended. These
forward-looking statements generally can be identified by phrases
such as Freedom Leaf, Inc. or its management "believes," "expects,"
"anticipates," "foresees," "forecasts," "estimates" or other words
or phrases of similar import. Similarly, statements herein that
describe the Company's business strategy, outlook, objectives,
plans, intentions or goals also are forward-looking statements. All
such forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements. Factors that could cause
or contribute to differences include the uncertainty regarding
viability and market acceptance of the Company's products and
services, changes in relationships with third parties, and other
factors described in the Company's most recent periodic filings
with the Securities and Exchange Commission, including its Annual
Report on Form 10-K dated June 30, 2016 and quarterly reports on
Form 10-Q.
Contact: Raymond Medeiros PR and Business Development Director Phone: 415-601-1974 ray@freedomleaf.com Freedom Leaf, Inc.